A Highly Selective and Sensitive LC–MS/HRMS Assay for Quantifying Coproporphyrins as Organic Anion-Transporting Peptide Biomarkers
Authors:
- 5 October 2017
- journal article
- Published by Taylor & Francis in Bioanalysis
- Vol. 9 (22) , 1787-1806
Abstract
Aim: Coproporphyrin-I (CP-I) and coproporphyrin-III (CP-III) in plasma and urine have been proposed as biomarkers for assessing drug–drug interactions involving hepatic drug transporters such as organic anion-transporting peptides (OATP), 1B1 and 1B3. Materials & methods: Plasma and urine extracts were analyzed for CP-I/CP-III using a TripleTOF API6600 mass spectrometer. Results: Previously unreported, CP-I/CP-III doubly charged ions (m/z 328.14) were used as precursor ions to improve the assay sensitivity and selectivity over the singly charged precursor ions (m/z 655.28). Levels of CP-I and CP-III measured ranged 0.45–1.1 and 0.050–0.50 ng/ml in plasma and 5–35 and 1–35 ng/ml in urine, respectively. Conclusion: The described highly selective and sensitive CP-I/CP-III LC–HRMS assay offers options for earlier characterization and clinical safety projections for OATP1B1/3-mediated drug–drug interactions along with pharmacokinetic analyses of a new chemical entity as part of first-in-human clinical studies.Keywords
This publication has 52 references indexed in Scilit:
- It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMSJournal of Mass Spectrometry, 2011
- Performance Characteristics of a New Hybrid Quadrupole Time-of-Flight Tandem Mass Spectrometer (TripleTOF 5600)Analytical Chemistry, 2011
- Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugsBritish Journal of Cancer, 2010
- Quantitative determination of hippuric and benzoic acids in urine by LC–MS/MS using surrogate standardsJournal of Pharmaceutical and Biomedical Analysis, 2010
- Quantification of coproporphyrin isomers I and III in urine by HPLC and determination of their ratio for investigations of Multidrug Resistance Protein 2 (MRP2) function in humansJournal of Chromatography B, 2009
- Metabolites in safety testing: metabolite identification strategies in discovery and developmentBiopharmaceutics & Drug Disposition, 2009
- Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analysesJournal of Chromatography B, 2007
- Foundation review: Principles and applications of LC-MS in new drug discoveryDrug Discovery Today, 2005
- Quantitation of Endogenous Analytes in Biofluid without a True Blank MatrixAnalytical Chemistry, 2003
- High-pressure liquid chromatography combined with fluorescence detection and solvent extraction for simultaneous determination of coproporphyrins I and III in human urineTalanta, 1983